The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease
Open Access
- 15 January 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Netherlands Heart Journal
- Vol. 19 (2), 85-88
- https://doi.org/10.1007/s12471-010-0069-x
Abstract
Expectations are high that increasing knowledge of the genetic basis of cardiovascular disease will eventually lead to personalised medicine—to preventive and therapeutic interventions that are targeted to at-risk individuals on the basis of their genetic profiles. Most cardiovascular diseases are caused by a complex interplay of many genetic variants interacting with many non-genetic risk factors such as diet, exercise, smoking and alcohol consumption. Since several years, genetic susceptibility testing for cardiovascular diseases is being offered via the internet directly to consumers. We discuss five reasons why these tests are not useful, namely: (1) the predictive ability is still limited; (2) the risk models used by the companies are based on assumptions that have not been verified; (3) the predicted risks keep changing when new variants are discovered and added to the test; (4) the tests do not consider non-genetic factors in the prediction of cardiovascular disease risk; and (5) the test results will not change recommendations of preventive interventions. Predictive genetic testing for multifactorial forms of cardiovascular disease clearly lacks benefits for the public. Prevention of disease should therefore remain focused on family history and on non-genetic risk factors as diet and physical activity that can have the strongest impact on disease risk, regardless of genetic susceptibility.Keywords
This publication has 26 references indexed in Scilit:
- Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery diseaseAmerican Heart Journal, 2010
- Translating Genomic Analyses into Improved Management of Coronary Artery DiseaseFuture Cardiology, 2010
- Active Cascade Screening in Primary Inherited Arrhythmia Syndromes: Does It Lead to Prophylactic Treatment?Journal of the American College of Cardiology, 2010
- DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness modelEuropean Heart Journal, 2010
- Association Between a Literature-Based Genetic Risk Score and Cardiovascular Events in WomenPublished by American Medical Association (AMA) ,2010
- Social Networkers' Attitudes Toward Direct-to-Consumer Personal Genome TestingAmerican Journal of Bioethics, 2009
- Personal Genome Testing: Do You Know What You Are Buying?American Journal of Bioethics, 2009
- Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3Annals of Internal Medicine, 2009
- A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial InfarctionScience, 2007
- Prediction of Coronary Heart Disease Using Risk Factor CategoriesCirculation, 1998